Prospective Randomized Trial of Sacubitril/Valsartan and Ramipril in Patients with HFrEF

Background: Heart failure with reduced ejection fraction (HFrEF) remains a leading cause of morbidity and mortality. This study aimed to compare the safety, efficacy, and quality of life outcomes of sacubitril/valsartan (an angiotensin receptor-neprilysin inhibitor, ARNI) versus ramipril (an ACE inhibitor) in HFrEF patients.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-28
DOI
https://doi.org/10.5281/zenodo.15762658
Primary Topic
Face Recognition and Perception
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospective Randomized Trial of Sacubitril/Valsartan and Ramipril in Patients with HFrEF

Zenodo (CERN European Organization for Nuclear Research)
Face Recognition and Perception
article

Prospective Randomized Trial of Sacubitril/Valsartan and Ramipril in Patients with HFrEF

article en

Abstract

Background: Heart failure with reduced ejection fraction (HFrEF) remains a leading cause of morbidity and mortality. This study aimed to compare the safety, efficacy, and quality of life outcomes of sacubitril/valsartan (an angiotensin receptor-neprilysin inhibitor, ARNI) versus ramipril (an ACE inhibitor) in HFrEF patients.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 51%
Face Recognition and Perception
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prospective Randomized Trial of Sacubitril/Valsartan and Ramipril in Patients with HFrEF · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS